Lataa...
Group B Streptococcus: global incidence and vaccine development
An ongoing public health challenge is to develop vaccines that are effective against infectious diseases that have global relevance. Vaccines against serotypes of group B Streptococcus (GBS) that are prevalent in the United States and Europe are not optimally efficacious against serotypes common to...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2742968/ https://ncbi.nlm.nih.gov/pubmed/17088932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrmicro1552 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|